Clinical trial
Long-term Special Drug Use Investigation of Molidustat for Patients With Renal Anemia
NCT04899661 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Special Drug Use Investigation of Molidustat for Patients With Renal Anemia
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- August 6, 2021
- Completion date
- September 30, 2027
- Enrollment
- 1,081 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal anemia